Unknown

Dataset Information

0

Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance.


ABSTRACT: We have developed a model of autoimmunity to investigate autoantibody-mediated cross-presentation of self antigen. RIP-mOVA mice, expressing OVA in pancreatic beta cells, develop severe autoimmune diabetes when given OT-I cells (OVA-specific CD8(+) T cells) and anti-OVA IgG but not when given T cells alone. Anti-OVA IgG is not directly injurious to the islets but rather enhances cross-presentation of apoptotic islet antigen to the OT-I cells, leading to their differentiation into potent effector cells. Antibody-driven effector T cell activation is dependent on the presence of activating Fc receptors for IgG (FcgammaRs) and cross-priming DCs. As a consequence, diabetes incidence and severity was reduced in mice lacking activating FcgammaRs. An intact complement pathway was also required for disease development, as C3 deficiency was also partially protective. C3-deficient animals exhibited augmented T cell priming overall, indicating a proinflammatory role for complement activation after the T cell priming phase. Thus, we show that autoreactive antibody can potently enhance the activation of effector T cells in response to cross-presented self antigen, thereby contributing to T cell-mediated autoimmunity.

SUBMITTER: Harbers SO 

PROVIDER: S-EPMC1849985 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6338877 | biostudies-literature
| S-EPMC2835175 | biostudies-literature
| S-EPMC6040178 | biostudies-literature
2010-05-08 | E-GEOD-15616 | biostudies-arrayexpress
| S-EPMC3858385 | biostudies-literature
2009-06-19 | GSE15616 | GEO
| S-EPMC3893022 | biostudies-literature
| S-EPMC3808998 | biostudies-literature
2019-01-23 | GSE121882 | GEO
| S-EPMC5835118 | biostudies-literature